According to the opinion of the Digest`s Editorial office, the main events of the April 2017 in Russian pharmaceutical industry are:
- investment in the Russian pharmaceutical sector has exceeded 1 billion euros;
- The Russian Antimonopoly agency has identified more than 70 cartel agreements on the pharmaceutical market;
- medicines, produced in Russia, are displaced from Ukrainian pharmacies;
- according to the research of Russian scientists, the number of counterfeit products in the pharmaceutical market grows every year;
- a new wave of appointments in the Russian pharmaceutical market.
These, as well as all other industry month news, are in the April 2017 issue of the Digest.
Andrei Egorov, Editor-in-Chief